[Abstract] In order to study the mechanism underlying the Hepatitis C Virus (HCV) fusion process we have performed assays using phospholipid liposomes and a truncated form of E2 protein, E2661 (amino acids 384-661 of the HCV polyprotein) lacking the transmembrane region. E2661 has been previously generated by using the baculovirus expression system. This form has been used in lipid-protein interaction studies with different model vesicles at different pHs, and monitored using a variety of fluorescent assays. After the analysis of the results, we observed that E2661 is able to insert into lipid bilayers and to induce vesicle aggregation, lipid mixing and liposome leakage, showing higher values of membrane destabilization for negatively charged phospholipids at acidic pH. This is indicative of the role of E2 glycoprotein in the HCV initial infective steps, interacting with the target membranes and producing their destabilization.
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2. Make a suspension of phospholipids at a concentration of 1 mg/ml in 1 ml of medium buffer at the appropriate pH value.
3. Incubate at 37 °C for 1 h in a water bath incubator without shaking and vortex vigorously every 10 min.
4. Sonicate the suspension for 10 min in a bath sonicator at a frequency of 40 kHz and subject to 15 cycles of extrusion in an extruder apparatus using 100 nm polycarbonate filters. For a successful extrusion process, avoid the formation of bubbles in the lipid suspension when inserting it into the syringe and squeeze the syringe plunger carefully and slowly.
It is recommended to prepare the lipid vesicles just before carrying out an experiment, although they may be stored for 1-2 days at 4 °C.
After vesicle preparation, the exact phospholipid concentration is calculated based on the phosphorus content determined according to Bartlett (1959 vesicles and the needed amount of medium buffer at the appropriate pH to reach a total volume of 500 μl. After gently mixing the solutions in 10 x 75 mm glass tubes, the final phospholipid and protein concentrations must be 0.14 mM and in the range of 0.2-3.5 μM, respectively. Use controls of lipid vesicles in the absence of protein and of protein in the absence of lipid.
2. Incubate at 37 °C for 1 h in a water bath incubator without shaking.
3. Measure the optical density at 360 nm (OD360) on a spectrophotometer, using a 1 x 0.2 cm absorption cuvette.
C. Lipid mixing assay
Note: This protocol is adapted from that described in Struck et al. (1981) 2. Mix labeled (1a) and unlabeled (1b) liposomes in a 1:9 molar proportion, maintaining the final lipid concentration of 1 mg/ml in a total volume of 1 ml. This mixed vesicle preparation is diluted ten times (100 μl + 900 μl of medium buffer) to a final concentration of 0.14 mM for lipid mixing assays.
3. Add different amounts (between 5 and 100 μl) of protein from a 15-30 μM stock solutions in 20 mM Tris pH 7.5, NaCl 100 mM. The final protein concentration must be in the range of 0.1-3 μM.
4. Incubate at 37 °C for 1 h in a water bath incubator without shaking. F0 is the fluorescence intensity at 530 nm of vesicles containing 1% NBD-PE and 0% Rh-PE.
D. Release of aqueous contents
Note: This protocol is adapted from that described in Ellens et al. (1985) . The assay is based on the dequenching of ANTS fluorescence caused by its dilution upon release of the aqueous contents of a vesicle preparation containing both ANTS and DPX.
1. The fluorophore ANTS and the quencher DPX must be co-encapsulated at a concentration of 12.5 and 45 mM respectively in either PG or PC phospholipid vesicles. For that purpose, weigh 13.4 mg of ANTS and 47.5 mg of DPX and dissolve in 2.5 ml of medium buffer at the appropriate pH value.
2. Add 2 ml of this solution to a lipid film (prepared according to Procedure A1) containing 2 mg of the appropriate phospholipid. Hydrate the film at 37 °C for 1 h in a water bath incubator without shaking, and sonicate for 30 min in a bath sonicator.
3. Subject the vesicles to five cycles of freeze-thawing in liquid nitrogen.
4. Extrude the vesicles at least 15 times through 100 nm polycarbonate filters (Avestin) by using an extruder apparatus.
5. Remove the non-encapsulated material by passing the sample through a Sephadex G-75 column using medium buffer at the appropriate pH value for elution. A typical column with 12-15 ml bed volume is prepared by swelling 1 g of dry Sephadex G75 in 20 ml of medium buffer for 24 h. After swelling is complete, decant supernatant, add buffer and degas the suspension.
For packing, pour the complete slurry into a glass column of 1-1.5 cm diameter. Run chromatography with a 1 ml/min flow rate, and collect 1 ml fractions. The encapsulated material elutes in the void volume in fractions with high turbidity, and therefore is detected by measuring the optical density at 360 nm of each fraction in a spectrophotometer, whereas the nonencapsulated free dyes elute in the column volume. Dilute the encapsulated vesicles to a final phospholipid concentration in the assay of 0.14 mM. where, -Fprot is the fluorescence intensity at 520 nm after the addition of E2 protein.
-F0 is the initial fluorescence intensity at 520 nm, before addition of the protein (0%).
-Fmax is the fluorescence intensity at 520 nm after addition of Triton X-100 (100%). 
Data analysis

A. Aggregation studies
The ability of E2661 to induce liposome aggregation was studied by measuring the increase of the optical density at 360 nm (OD360) due to scattering of a phospholipid suspension. The results obtained at pH 5.0 and pH 7.0 for both PC and PG vesicles at different phospholipid/protein ratios are depicted in Figure 1 . The analysis of the initial rate of these processes indicates that aggregation was almost instantaneous. In all cases, the OD360 values were dependent on the E2661 concentration and became saturated as the protein concentration increased. 
C. Release of aqueous content
The ability to cause the release of the aqueous contents of phospholipid vesicles was also used to check the destabilization properties of E2661. Liposome leakage was monitored by the dilution of the co-encapsulated fluorophore ANTS and its collisional quencher DPX, which leads to a rapid increase in ANTS fluorescence at 520 nm (Ellens et al., 1985) . The leakage induced by the protein added to PG or PC phospholipid suspensions at the two pH values tested is shown in Figure 3 . This process induced on neutral phospholipid vesicles was lower than that observed for PG vesicles suggesting the importance of the electrostatic component on the protein-lipid interactions. 
